Cargando…
FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway
Aberrant Wnt/β-catenin pathway activation is frequently observed in human colorectal cancer (CRC) and has become a promising target for CRC treatment. Our study aimed to evaluate the effect of FH535, a small molecule inhibitor of Wnt/β-catenin pathway, on two colon cancer cell lines, HT29 and SW480....
Autores principales: | Chen, Yanyan, Rao, Xianping, Huang, Kangmao, Jiang, Xiaoxia, Wang, Haohao, Teng, Lisong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665030/ https://www.ncbi.nlm.nih.gov/pubmed/29158786 http://dx.doi.org/10.7150/jca.19273 |
Ejemplares similares
-
Targeting the Wnt/β-Catenin Signaling Pathway in Liver Cancer Stem Cells and Hepatocellular Carcinoma Cell Lines with FH535
por: Gedaly, Roberto, et al.
Publicado: (2014) -
FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases
por: Gustafson, Carl T., et al.
Publicado: (2017) -
FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis
por: Liu, Lu, et al.
Publicado: (2016) -
FH535 Inhibited Migration and Growth of Breast Cancer Cells
por: Iida, Joji, et al.
Publicado: (2012) -
FH535 inhibited metastasis and growth of pancreatic cancer cells
por: Wu, Meng-Yao, et al.
Publicado: (2015)